CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-16 | ROBIN HOWARD W President & CEO | Returned to the company · Restricted Stock Unit | −5,625 | 61,875 | ||
| 2016-02-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Exercise or conversion | +875 | $0.00 | $0 | 875 |
| 2016-02-16 | Doberstein Stephen K SVP & Chief Scientific Officer | Returned to the company · Restricted Stock Unit | −875 | 9,625 | ||
| 2016-02-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +1,875 | $0.00 | $0 | 5,874 |
| 2016-02-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Returned to the company · Restricted Stock Unit | −1,875 | 20,625 | ||
| 2016-02-16 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion | +2,166 | $0.00 | $0 | 7,417 |
| 2016-02-16 | Labrucherie Gil M SVP & General Counsel | Returned to the company · Restricted Stock Unit | −2,166 | 23,834 | ||
| 2016-02-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Exercise or conversion | +2,166 | $0.00 | $0 | 6,766 |
| 2016-02-16 | Hora Maninder SVP Pharma Dev & Mfg Ops | Returned to the company · Restricted Stock Unit | −2,166 | 23,834 | ||
| 2016-02-10 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion | +11,666 | $6.46 | $75K | 16,917 |
| 2016-02-10 | Labrucherie Gil M SVP & General Counsel | Sale | −11,666 | $11.49 | $134K | 5,251 |
| 2016-02-10 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion · Stock Option | −11,666 | 0 | ||
| 2016-02-10 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +15,000 | $6.65 | $100K | 18,999 |
| 2016-02-10 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −15,000 | $11.49 | $172K | 3,999 |
| 2016-02-10 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −15,000 | 15,000 | ||
| 2016-02-10 | ROBIN HOWARD W President & CEO | Exercise or conversion | +66,666 | $6.46 | $431K | 76,666 |
| 2016-02-10 | ROBIN HOWARD W President & CEO | Sale | −66,666 | $11.49 | $766K | 10,000 |
| 2016-02-10 | ROBIN HOWARD W President & CEO | Exercise or conversion · Stock Option | −66,666 | 0 | ||
| 2016-02-03 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2016-01-20 | Lingnau Lutz Director | Exercise or conversion | +15,000 | $5.15 | $77K | 31,450 |
Page 54 of 55 · 1,088 trades